Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    The Looming Gold Production Cliff That Will Drive Prices Higher

    Country Canada maple leaf

    In recent years, global gold production has been at or near record levels. The plentiful supplies have led gold bears to argue that the yellow metal's decade-long bull run will end.

    But gold bears are dead wrong.

    In fact, the 'glory days' of gold production may be ending soon.

    That's because some industry experts are beginning to point to a gold "production cliff' that is looming not far in the future.

    And this coming decline in production can mean only one thing: higher gold prices.

    To continue reading, please click here...


    Read More...
  • gold production cliff